Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Fluticasone Propionate in Mild to Moderate Asthma
NCT00163423Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2004
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoints: Forced Expiratory Volume in 1 Second and Time to the first asthma exacerbation. Started Nov 2004; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00163423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163423.